Use of 2 anti-SPARC antibodies to predict response to chemotherapy

Details for Australian Patent Application No. 2010253747 (hide)

Owner Abraxis BioScience, LLC

Inventors Trieu, Vuong; Desai, Neil; Knauer, Daniel

Agent Pizzeys

Pub. Number AU-A-2010253747

PCT Pub. Number WO2010/138839

Priority 61/182,081 28.05.09 US

Filing date 28 May 2010

Wipo publication date 2 December 2010

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/138839 Priority application(s): WO2010/138839

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010253749-Methods and apparatus for performing knee arthroplasty

2010253744-Methods and apparatus for performing knee arthroplasty